1-3 of 3
Christine Lihou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Study of INCB057643 Monotherapy in Patients with Relapsed or Refractory Myelofibrosis (INCB 57643-103)

Christine Lihou, BS, Gongfu Zhou, PhD, Fred Zheng, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-134604
Published: 2020
Journal Articles

Interim Results from Fight-203, a Phase 2, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Pemigatinib (INCB054828) in Patients with Myeloid/Lymphoid Neoplasms with Rearrangement of Fibroblast Growth Factor Receptor 1 ( FGFR1 )

Srdan Verstovsek, MD PhD, Alessandro M. Vannucchi, MD, Alessandro Rambaldi, MD PhD, Jason R. Gotlib, MDMS, Adam J. Mead, MD PhD, Andreas Hochhaus, MD, Jean-Jacques Kiladjian, MD PhD, Juan Carlos Hernandez Boluda, MD PhD, Ekaterine Asatiani, MD, Christine Lihou, BS, Huiling Zhen, MD PhD, Andreas Reiter, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 690.
https://doi.org/10.1182/blood-2018-99-110388
Published: 2018
Journal Articles

CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb) - Preliminary Results of Subjects with Castleman’s Disease from a Phase 1 Study in Selected Hematological Malignancies.

Frits VanRhee, MD, PhD, FRCPath, MRCP, Luis Fayad, MD, Hossein Borghaei, OD, MS, Peter M. Voorhees, MD, Robert Z. Orlowski, MD,PhD, Richard R. Furman, MD, Mohamed Zaki, MD,PhD, Uma Prabhakar, Trina Jiao, Christine Lihou, Carlos A. Garay, MD, Razelle Kurzrock, MD, FACP
Journal: Blood
Blood (2006) 108 (11): 2728.
https://doi.org/10.1182/blood.V108.11.2728.2728
Published: 2006